OGEN insider plans Rule 144 sale of 210 common shares

A holder of OGEN common stock has filed a notice of proposed sale under Rule 144.

Rhea-AI Filing Summary

A holder of OGEN common stock has filed a notice of proposed sale under Rule 144. The filing covers the planned sale of 210 shares of common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of 191.94. The shares relate to an issuer that had 4,168,223 shares outstanding at the time stated. The seller acquired 171 shares as restricted stock units on 06/17/2022 and 39 shares as restricted stock units on 11/20/2020, both described as compensation from the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for OGEN disclose?

It discloses that a holder of OGEN common stock plans to sell 210 shares under Rule 144 through Goldman Sachs & Co. LLC on the NYSE.

How many OGEN shares are proposed to be sold and at what market value?

The notice covers 210 shares of common stock with an aggregate market value of 191.94 as stated in the filing.

When was the planned OGEN share sale expected to occur?

The approximate date of sale listed is 12/12/2025.

How many OGEN shares were outstanding according to this notice?

The filing reports 4,168,223 shares of common stock outstanding for the issuer at the time stated.

How did the seller acquire the OGEN shares listed in the Form 144?

The seller acquired 171 shares on 06/17/2022 and 39 shares on 11/20/2020 as restricted stock units received as compensation from the issuer.

Which broker is handling the planned OGEN Rule 144 sale?

The broker named is Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 06:28 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001382225
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Oragenics, Inc.
SEC File Number	001-32188
Address of Issuer	1990 Main Street Suite 750 Sarasota FLORIDA 34236
Phone	1-813-286-7900
Name of Person for Whose Account the Securities are To Be Sold	Frederick W. Telling
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	210	191.94	4168223	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/17/2022	Acquired as compensation -- Restricted Stock Units	Issuer			171	06/17/2022	Compensation
Common	11/20/2020	Acquired as compensation -- Restricted Stock Units	Issuer			39	11/20/2020	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Frederick W. Telling
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)